Literature DB >> 2415138

Carbohydrate-containing derivatives of the trypsin-kallikrein inhibitor aprotinin from bovine organs. II. Inhibitor coupled to the (carboxymethyl)dextran derivatives of D-galactose.

N I Larionova, G V Mityushina, N F Kazanskaya, Y A Blidchenko, I V Berezin.   

Abstract

The trypsin-kallikrein inhibitor aprotinin was coupled to (carboxymethyl)dextran derivatives of D-galactose. The conjugates contained 14 and 38 D-galactose residues/mol of protein, respectively. The apparent dissociation constants Ki of the complexes between trypsin and modified aprotinins proved to be one order of magnitude higher than the respective values for native aprotinin. The distribution of the modified aprotinins in rat organs after endocardial injection has been studied. The conjugates of aprotinin with (carboxymethyl)dextran derivatives of D-galactose were characterized by decreased clearance rates; they accumulated in the active form in liver. The accumulation was 2.5-10 times higher than native aprotinin for the time of observation (5 min-2 h).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2415138     DOI: 10.1515/bchm3.1985.366.2.743

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  3 in total

1.  Inhibition of liver metastasis in mice by blocking hepatocyte lectins with arabinogalactan infusions and D-galactose.

Authors:  J Beuth; H L Ko; K Oette; G Pulverer; K Roszkowski; G Uhlenbruck
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

2.  Prevention of experimental liver metastases by arabinogalactan.

Authors:  G Uhlenbruck; J Beuth; K Oette; W Roszkowski; H L Ko; G Pulverer
Journal:  Naturwissenschaften       Date:  1986-10

3.  Prevention of experimental liver metastases by D-galactose.

Authors:  G Uhlenbruck; J Beuth; K Oette; H L Ko; G Pulverer
Journal:  Experientia       Date:  1987-04-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.